Wheaton Little

Wheaton Little serves as the Vice President and Head of Neuroscience Discovery Research and Non-Clinical Pharmacology at Jazz Pharmaceuticals, where leadership is focused on driving pipeline sustainability for next-generation medicines. Previous experience includes tenure at Takeda, where as Executive Director, Wheaton led the Neuroscience Drug Discovery Unit, contributing to a robust portfolio associated with significant funding and clinical candidates. Prior roles at GSK encompassed various leadership positions in neuroscience strategy and operations, including directing external CNS research and establishing novel discovery programs. Wheaton holds a PhD in Molecular Biology from the University of Cambridge and a B.S. in Biochemistry from Haverford College, graduating summa cum laude.